vs

Side-by-side financial comparison of CARRIAGE SERVICES INC (CSV) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.

CARRIAGE SERVICES INC is the larger business by last-quarter revenue ($105.5M vs $75.5M, roughly 1.4× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 8.0%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $6.2M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 1.0%).

Jardine Cycle & Carriage Limited is the investment holding company of Jardines in Southeast Asia. It is currently 75% held by the conglomerate.

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

CSV vs PBYI — Head-to-Head

Bigger by revenue
CSV
CSV
1.4× larger
CSV
$105.5M
$75.5M
PBYI
Growing faster (revenue YoY)
PBYI
PBYI
+19.8% gap
PBYI
27.7%
8.0%
CSV
More free cash flow
PBYI
PBYI
$8.2M more FCF
PBYI
$14.4M
$6.2M
CSV
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
1.0%
CSV

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CSV
CSV
PBYI
PBYI
Revenue
$105.5M
$75.5M
Net Profit
$12.3M
Gross Margin
34.8%
69.3%
Operating Margin
23.3%
22.7%
Net Margin
11.6%
Revenue YoY
8.0%
27.7%
Net Profit YoY
24.5%
EPS (diluted)
$0.76
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CSV
CSV
PBYI
PBYI
Q4 25
$105.5M
$75.5M
Q3 25
$102.7M
$54.5M
Q2 25
$102.1M
$52.4M
Q1 25
$107.1M
$46.0M
Q4 24
$97.7M
$59.1M
Q3 24
$100.7M
$80.5M
Q2 24
$102.3M
$47.1M
Q1 24
$103.5M
$43.8M
Net Profit
CSV
CSV
PBYI
PBYI
Q4 25
$12.3M
Q3 25
$6.6M
$8.8M
Q2 25
$11.7M
$5.9M
Q1 25
$20.9M
$3.0M
Q4 24
$9.9M
Q3 24
$9.9M
$20.3M
Q2 24
$6.3M
$-4.5M
Q1 24
$7.0M
$-4.8M
Gross Margin
CSV
CSV
PBYI
PBYI
Q4 25
34.8%
69.3%
Q3 25
35.3%
77.7%
Q2 25
35.2%
76.5%
Q1 25
35.3%
77.1%
Q4 24
34.4%
76.4%
Q3 24
35.2%
63.9%
Q2 24
36.2%
77.4%
Q1 24
36.0%
75.5%
Operating Margin
CSV
CSV
PBYI
PBYI
Q4 25
23.3%
22.7%
Q3 25
17.0%
17.6%
Q2 25
23.5%
12.7%
Q1 25
29.5%
8.7%
Q4 24
21.6%
22.6%
Q3 24
22.7%
27.4%
Q2 24
18.0%
-4.6%
Q1 24
18.8%
-5.3%
Net Margin
CSV
CSV
PBYI
PBYI
Q4 25
11.6%
Q3 25
6.4%
16.2%
Q2 25
11.5%
11.2%
Q1 25
19.5%
6.5%
Q4 24
10.1%
Q3 24
9.8%
25.2%
Q2 24
6.1%
-9.6%
Q1 24
6.7%
-11.0%
EPS (diluted)
CSV
CSV
PBYI
PBYI
Q4 25
$0.76
$0.26
Q3 25
$0.41
$0.17
Q2 25
$0.74
$0.12
Q1 25
$1.34
$0.06
Q4 24
$0.62
$0.40
Q3 24
$0.63
$0.41
Q2 24
$0.40
$-0.09
Q1 24
$0.45
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CSV
CSV
PBYI
PBYI
Cash + ST InvestmentsLiquidity on hand
$1.7M
$97.5M
Total DebtLower is stronger
$22.7M
Stockholders' EquityBook value
$254.8M
$130.3M
Total Assets
$1.3B
$216.3M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CSV
CSV
PBYI
PBYI
Q4 25
$1.7M
$97.5M
Q3 25
$1.2M
$94.4M
Q2 25
$1.4M
$96.0M
Q1 25
$4.6M
$93.2M
Q4 24
$1.2M
$101.0M
Q3 24
$1.3M
$96.7M
Q2 24
$1.5M
$96.8M
Q1 24
$1.7M
$107.2M
Total Debt
CSV
CSV
PBYI
PBYI
Q4 25
$22.7M
Q3 25
$34.0M
Q2 25
$45.3M
Q1 25
$56.7M
Q4 24
$68.0M
Q3 24
$79.3M
Q2 24
$90.7M
Q1 24
$102.0M
Stockholders' Equity
CSV
CSV
PBYI
PBYI
Q4 25
$254.8M
$130.3M
Q3 25
$242.1M
$115.3M
Q2 25
$235.4M
$104.7M
Q1 25
$223.1M
$97.1M
Q4 24
$208.6M
$92.1M
Q3 24
$198.1M
$71.1M
Q2 24
$187.9M
$48.5M
Q1 24
$179.6M
$51.0M
Total Assets
CSV
CSV
PBYI
PBYI
Q4 25
$1.3B
$216.3M
Q3 25
$1.3B
$202.9M
Q2 25
$1.3B
$194.9M
Q1 25
$1.3B
$196.2M
Q4 24
$1.3B
$213.3M
Q3 24
$1.3B
$220.7M
Q2 24
$1.3B
$205.0M
Q1 24
$1.3B
$214.1M
Debt / Equity
CSV
CSV
PBYI
PBYI
Q4 25
0.17×
Q3 25
0.30×
Q2 25
0.43×
Q1 25
0.58×
Q4 24
0.74×
Q3 24
1.12×
Q2 24
1.87×
Q1 24
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CSV
CSV
PBYI
PBYI
Operating Cash FlowLast quarter
$14.1M
$14.4M
Free Cash FlowOCF − Capex
$6.2M
$14.4M
FCF MarginFCF / Revenue
5.9%
19.1%
Capex IntensityCapex / Revenue
7.5%
0.0%
Cash ConversionOCF / Net Profit
1.15×
TTM Free Cash FlowTrailing 4 quarters
$40.1M
$41.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CSV
CSV
PBYI
PBYI
Q4 25
$14.1M
$14.4M
Q3 25
$24.7M
$9.7M
Q2 25
$8.1M
$14.1M
Q1 25
$13.8M
$3.6M
Q4 24
$9.3M
$15.6M
Q3 24
$20.9M
$11.0M
Q2 24
$2.2M
$1.0M
Q1 24
$19.7M
$11.2M
Free Cash Flow
CSV
CSV
PBYI
PBYI
Q4 25
$6.2M
$14.4M
Q3 25
$18.0M
$9.7M
Q2 25
$5.2M
$14.1M
Q1 25
$10.6M
$3.6M
Q4 24
$4.9M
$15.6M
Q3 24
$16.2M
$11.0M
Q2 24
$-1.4M
$1.0M
Q1 24
$16.2M
FCF Margin
CSV
CSV
PBYI
PBYI
Q4 25
5.9%
19.1%
Q3 25
17.5%
17.7%
Q2 25
5.1%
26.8%
Q1 25
9.9%
7.7%
Q4 24
5.0%
26.4%
Q3 24
16.1%
13.7%
Q2 24
-1.4%
2.1%
Q1 24
15.6%
Capex Intensity
CSV
CSV
PBYI
PBYI
Q4 25
7.5%
0.0%
Q3 25
6.5%
0.0%
Q2 25
2.8%
0.0%
Q1 25
3.0%
0.1%
Q4 24
4.5%
0.0%
Q3 24
4.6%
0.0%
Q2 24
3.5%
0.0%
Q1 24
3.4%
0.0%
Cash Conversion
CSV
CSV
PBYI
PBYI
Q4 25
1.15×
Q3 25
3.76×
1.10×
Q2 25
0.69×
2.41×
Q1 25
0.66×
1.21×
Q4 24
0.94×
Q3 24
2.11×
0.54×
Q2 24
0.34×
Q1 24
2.83×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CSV
CSV

Propertyand Merchandise$47.8M45%
Cemetery Interment Rights$24.8M23%
Merchandise$18.9M18%
Other Revenue$10.2M10%
Other$3.9M4%

PBYI
PBYI

Segment breakdown not available.

Related Comparisons